Tramutola A, Triplett JC, Di Domenico F, Niedowicz DM, Murphy MP, Coccia R, Perluigi M, Butterfield DA (2015) Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD
10.3748/wjg.v12.i17.2661 3
Ji S, Cesario D, Valderrabano M, et al
Phosphorous - Harvard School of Public Health - The Nutrition Source
So, pharmaceutical companies started investigating the use of GLP-1s for weight-management purposes, and the first GLP-1 weight-loss drug, Saxenda (liraglutide), was approved by FDA in 2014 (it was previously approved to treat diabetes under the name Victoza)
The concentrations and yields of GSH based on l-cysteine for these engineered strains are shown in Fig